tiprankstipranks
Advertisement
Advertisement

OGEN Stock Latest News

Oragenics announces 8 drug doses administered in Phase IIa trial of ONP-002
The FlyOragenics announces 8 drug doses administered in Phase IIa trial of ONP-002
16d ago
OGEN
Oragenics begins Phase IIa dosing of concussion drug ONP-002 in Australia
PremiumCompany Announcements
Oragenics begins Phase IIa dosing of concussion drug ONP-002 in Australia
23d ago
OGEN
Oragenics Sets New 2025 Annual Shareholder Meeting Date
PremiumCompany Announcements
Oragenics Sets New 2025 Annual Shareholder Meeting Date
1M ago
8K
OGEN
Oragenics receives audit opinion with going concern explanation
PremiumThe Fly
Oragenics receives audit opinion with going concern explanation
1M ago
OGEN
Oragenics files annual report on Form 10-K
PremiumThe Fly
Oragenics files annual report on Form 10-K
2M ago
OGEN
Oragenics initiates Phase IIa clinical trial site activation
PremiumThe FlyOragenics initiates Phase IIa clinical trial site activation
2M ago
OGEN
Oragenics Advances Concussion Drug Trial and Explores CNS Asset Acquisitions
Premium
Company Announcements
Oragenics Advances Concussion Drug Trial and Explores CNS Asset Acquisitions
2M ago
OGEN
Oragenics explores potential acquisition of additional assets in CNS space
Premium
The Fly
Oragenics explores potential acquisition of additional assets in CNS space
2M ago
OGEN
Oragenics receives HREC approval for Phase IIa trial of ONP-002 in Australia
PremiumThe Fly
Oragenics receives HREC approval for Phase IIa trial of ONP-002 in Australia
2M ago
OGEN
Oragenics previews targeted milestones for 2026
PremiumThe Fly
Oragenics previews targeted milestones for 2026
3M ago
OGEN
Oragenics partners with Duck Flats Pharma to support FDA IND trial design
PremiumThe Fly
Oragenics partners with Duck Flats Pharma to support FDA IND trial design
3M ago
OGEN
Oragenics Extends At-the-Market Equity Sales Agreement
PremiumCompany Announcements
Oragenics Extends At-the-Market Equity Sales Agreement
3M ago
8K
OGEN
Oragenics files $100M mixed securities shelf
PremiumThe FlyOragenics files $100M mixed securities shelf
3M ago
OGEN
Oragenics Adjusts Executive Compensation Plan
Premium
Company Announcements
Oragenics Adjusts Executive Compensation Plan
5M ago
8K
OGEN
Oragenics Regains NYSE Compliance After Public Offering
Premium
Company Announcements
Oragenics Regains NYSE Compliance After Public Offering
7M ago
8K
OGEN
Oragenics regains compliance with NYSE
PremiumThe Fly
Oragenics regains compliance with NYSE
7M ago
OGEN
Oragenics, Receptor.AI partner to accelerate pipeline development
PremiumThe Fly
Oragenics, Receptor.AI partner to accelerate pipeline development
7M ago
OGEN
Oragenics Appoints Natasha Giordano to Board of Directors
PremiumCompany Announcements
Oragenics Appoints Natasha Giordano to Board of Directors
8M ago
8K
OGEN
Oragenics reports Q2 EPS ($3.10) vs. ($15.27) last year.
PremiumThe Fly
Oragenics reports Q2 EPS ($3.10) vs. ($15.27) last year.
9M ago
OGEN
Oragenics selects South Star Research as its CRO for ONP-002 Phase IIa trial
PremiumThe FlyOragenics selects South Star Research as its CRO for ONP-002 Phase IIa trial
9M ago
OGEN
Oragenics announces manufacturing agreement with Sterling Pharma for ONP-002
Premium
The Fly
Oragenics announces manufacturing agreement with Sterling Pharma for ONP-002
10M ago
OGEN
Oragenics Raises $16.5M Through Public Offering
Premium
Company Announcements
Oragenics Raises $16.5M Through Public Offering
10M ago
8K
OGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >